Examining The Effect of Chronotype Differences on Sleep Quality and Pregnancy Symptoms in Pregnant Women
NCT ID: NCT06413784
Last Updated: 2024-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2022-04-01
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Eighty-five pregnant women in the second trimester were included in the study. The chronotypes of pregnant women were determined using the Morningness-Eveningness Questionnaire (MEQ). Then, Oral Glucose Tolerance tests were performed on the participants between 24-28 weeks. Also, pregnant women's nausea and vomiting conditions with the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) and sleep quality with Pittsburgh Sleep Quality Index (PSQI) were evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Pregnant Pıllow on Sleep and Comfort
NCT05790018
Sleep Disturbances in the 2nd and 3rd Trimester
NCT03763071
The Effects of the Mindfulness-Based Pregnancy Stress Reduction Program on Pregnant Women
NCT06924879
Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine
NCT04336787
Effects of Yoga on Sleep and Stress in the Third Trimester of Pregnancy
NCT07085026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: This study is a single-blind (participants), parallel trial. It was performed in line with the principles of the Declaration of Helsinki. The followings were the study's inclusion requirements: being between the ages of 18-40, having a singleton pregnancy, being in the second trimester, and not having any known chronic disease. Exclusion criteria are working night shifts, having a high-risk pregnancy, and having a neurological or orthopedic disease. Eighty-five pregnant women in the second trimester were included in the study. The chronotypes of pregnant women were determined using the Morningness-Eveningness Questionnaire (MEQ). Then, Oral Glucose Tolerance tests were performed on the participants between 24-28 weeks. Also, pregnant women's nausea and vomiting conditions with the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) and sleep quality with Pittsburgh Sleep Quality Index (PSQI) were evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Morning Chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of morning chronotype individuals were examined.
Morning chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of morning chronotype individuals were examined.
Intermediate chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of Intermediate chronotype individuals were examined.
Intermediate chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of intermediate chronotype individuals were examined.
Evening chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of evening chronotype individuals were examined.
Evening chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of evening chronotype individuals were examined.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morning chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of morning chronotype individuals were examined.
Intermediate chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of intermediate chronotype individuals were examined.
Evening chronotype
Sleep quality, gestational diabetes and pregnancy symptoms of evening chronotype individuals were examined.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having a singleton pregnancy, being in the second trimester,
* not having any known chronic disease.
Exclusion Criteria
* having a high-risk pregnancy,
* having a neurological or orthopedic disease.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
merve yilmaz menek
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MERVE YILMAZ MENEK, PhD
Role: PRINCIPAL_INVESTIGATOR
Medipol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medipol University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cassidy EM, Bailey CP, Napolitano MA, Vyas AN. Sleep duration and chronotype of pregnant women in the United States: An online cross-sectional survey study. Prev Med Rep. 2022 Dec 6;31:102088. doi: 10.1016/j.pmedr.2022.102088. eCollection 2023 Feb.
Related Links
Access external resources that provide additional context or updates about the study.
Sleep duration and chronotype of pregnant women in the United States: An online cross-sectional survey study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10840098-772.02-6181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.